Clarification from Gavi, the Vaccine Alliance
Geneva, 30 April 2015 - Following a recent newspaper report regarding the relationship between Gavi, the Vaccine Alliance and India, Gavi would like to clarify the following points:
- An article published recently in an Indian newspaper stated that Gavi was withdrawing funding from India, thereby jeopardising the Government of India’s ongoing efforts to improve immunisation coverage. That is not the case.
- Gavi remains a committed partner of India and we will continue to support the country in its endeavours to immunise more of its children against life-threatening diseases.
- Thanks to its growing economy, India is projected to reach the threshold of US$ 1,580 Gross National Income per capita which means it has entered what is known as the ‘graduation’ phase in relation to Gavi support.
- Over the next five years, Gavi and India will work together towards financing the introductions of some new vaccines and assuring that these will ultimately have budget provisions within the Government of India budget so that children in India continue to have access to vaccines for generations to come.
- Gavi applauds the excellent work by the Government of India to improve immunisation coverage under Mission Indradhanush and its work to protect the lives of children living in 201 of the most at risk districts in the country.
Gavi’s work with India
- Gavi currently supports pentavalent vaccine which offers protection against five diseases (diphtheria-tetanus-pertussis (DTP), hepatitis B, and Haemophilius influenzae type b (Hib) as well as providing funding to help India to strengthen its health systems.
- Between 2000 and 2015, Gavi has disbursed more than US$ 240 million to help India to immunse its children against life-threatening diseases. Additionally, Gavi has committed $107 million to support health systems strengthening in India, which is likely to play a role in the success of Mission Indradhanush, over the next five years.